Peter A. Thompson
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 12 years
- Director since
- 2023
12 years of board service in total across 5 boards, counting each seat separately. Longest: Edgewise Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Sionna Therapeutics Inc. June 17, 202694.4%
-
ARS Pharmaceuticals Inc. June 25, 202591.0%
-
Corvus Pharmaceuticals Inc. June 12, 202598.9%
-
Edgewise Therapeutics Inc. June 7, 202479.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +196,541 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +642,745 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +616,984 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +625,743 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Derivative conversion | +507,119 | — | — |
| Nov 2, 2026 | Aspen Neuroscience Inc. | Open-market purchase | +1,000,000 | $15.00 | $15,000,000 |
| Jul 7, 2026 | Sionna Therapeutics Inc. | Open-market sale | −85,918 | $44.86 | $3,854,281 |
| Jun 30, 2026 | Sionna Therapeutics Inc. | Open-market sale | −115,844 | $45.50 | $5,270,902 |
| May 27, 2026 | Sionna Therapeutics Inc. | Open-market sale | −101 | $44.49 | $4,493 |
| May 11, 2026 | Sionna Therapeutics Inc. | Open-market sale | −184,639 | $46.22 | $8,534,015 |
| May 8, 2026 | Sionna Therapeutics Inc. | Open-market sale | −59,767 | $44.58 | $2,664,413 |
| May 7, 2026 | Sionna Therapeutics Inc. | Open-market sale | −48,546 | $44.61 | $2,165,637 |
| Apr 18, 2026 | Sionna Therapeutics Inc. | Open-market sale | −2,948 | $44.52 | $131,245 |
| Apr 17, 2026 | Sionna Therapeutics Inc. | Open-market sale | −52,397 | $44.68 | $2,341,098 |
| Apr 16, 2026 | Sionna Therapeutics Inc. | Open-market sale | −226,906 | $45.34 | $10,287,918 |
Questions about Peter A. Thompson
What boards is Peter A. Thompson on?
Peter A. Thompson sits on the boards of ARS Pharmaceuticals Inc., Aspen Neuroscience Inc., Corvus Pharmaceuticals Inc., Edgewise Therapeutics Inc. and Sionna Therapeutics Inc.
How long has Peter A. Thompson served on boards?
Our records show at least 12 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.